Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication
暂无分享,去创建一个
R. Holle | C. Vogelmeier | J. Ficker | D. Nowak | F. Biertz | S. Söhler | R. Jörres | R. Huber | M. Wacker | H. Mückter | T. Lucke | R. Herrera
[1] R. Holle,et al. The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline. , 2016, Respiratory medicine.
[2] R. Holle,et al. Direct and indirect costs of COPD and its comorbidities: Results from the German COSYCONET study. , 2016, Respiratory medicine.
[3] J. Thumboo,et al. Comparison of the Charlson Comorbidity Index derived from self-report and medical record review in Asian patients with rheumatic diseases , 2015, Rheumatology International.
[4] A. Scheen,et al. Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control. , 2015, Diabetes & metabolism.
[5] C. Paúl,et al. Determinants of frailty: the added value of assessing medication , 2015, Front. Aging Neurosci..
[6] Changwei Li,et al. Validity of self-reported diabetes among middle-aged and older Chinese adults: the China Health and Retirement Longitudinal Study , 2015, BMJ Open.
[7] B. Cosío,et al. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity? , 2014, International journal of chronic obstructive pulmonary disease.
[8] K. Farrington,et al. A self-report comorbidity questionnaire for haemodialysis patients , 2014, BMC Nephrology.
[9] Javier A. Neyra,et al. Hemodialysis catheter insertion: is increased PO2 a sign of arterial cannulation? A case report , 2014, BMC Nephrology.
[10] A. Menezes,et al. Comorbidities and Health Status in Individuals With and Without COPD in Five Latin American Cities: The PLATINO Study ☆ , 2013 .
[11] J. Jardim,et al. Comorbilidades y estado de salud en individuos con y sin EPOC en 5 ciudades de América Latina: Estudio PLATINO , 2013 .
[12] L. Edwards,et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. , 2013, Respiratory medicine.
[13] C. Teljeur,et al. Multimorbidity in a cohort of patients with type 2 diabetes , 2013, The European journal of general practice.
[14] Bruce Leff,et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008 , 2012, BMC Pulmonary Medicine.
[15] A. Lindberg,et al. Up-to-date on mortality in COPD - report from the OLIN COPD study , 2012, BMC Pulmonary Medicine.
[16] R. Pistelli,et al. Common geriatric conditions and disabilities in older persons with chronic obstructive pulmonary disease , 2011, Current opinion in pulmonary medicine.
[17] C. Dowrick,et al. The association between chronic illness, multimorbidity and depressive symptoms in an Australian primary care cohort , 2012, Social Psychiatry and Psychiatric Epidemiology.
[18] R. Marrie,et al. Validation of a Self-Report Comorbidity Questionnaire for Multiple Sclerosis , 2010, Neuroepidemiology.
[19] C. Vogelmeier,et al. Einfluss systemischer Manifestationenund Komorbiditäten auf den klinischen Zustand und den Verlaufbei COPD , 2010 .
[20] C. Vogelmeier,et al. [Systemic manifestations and comorbidities in patients with chronic obstructive pulmonary disease (COPD) and their effect on clinical state and course of the disease--an overview of the cohort study COSYCONET]. , 2010, Deutsche medizinische Wochenschrift.
[21] M. Marzilli. Pleiotropic Effects of Statins , 2010, American journal of cardiovascular drugs : drugs, devices, and other interventions.
[22] M. Casas,et al. A method to estimate expected day-surgery activity in hospitals of the Spanish National Health System , 2008, BMC Health Services Research.
[23] Manfred Stommel,et al. "Concordance between comorbidity data from patient self-report interviews and medical record documentation" , 2008, BMC health services research.
[24] Kenneth D. Mandl,et al. Research Paper: The Value of Patient Self-report for Disease Surveillance , 2007, J. Am. Medical Informatics Assoc..
[25] P. Calverley,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.
[26] Carol M. Mangione,et al. What is the Concordance Between the Medical Record and Patient Self-Report as Data Sources for Ambulatory Care? , 2006, Medical care.
[27] Robert A. Israel,et al. International Classification of Diseases (ICD) , 2005 .
[28] U. Laufs,et al. Pleiotropic effects of statins. - Basic research and clinical perspectives -. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[29] Douglas W Mahoney,et al. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. , 2004, Journal of clinical epidemiology.
[30] R. J. Brown,et al. Reliability of self-reported diagnoses in patients with neurologically unexplained symptoms , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[31] L. Fried,et al. Agreement Between Self‐Report of Disease Diagnoses and Medical Record Validation in Disabled Older Women: Factors That Modify Agreement , 2004, Journal of the American Geriatrics Society.
[32] Paul A. Fishman,et al. Risk Adjustment Using Automated Ambulatory Pharmacy Data: The RxRisk Model , 2003, Medical care.
[33] J. Farmer. Pleiotropic effects of statins , 2000, Current atherosclerosis reports.
[34] B. Penninx,et al. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. , 1996, Journal of clinical epidemiology.